APO Research
Talk to an analyst

APO RESEARCH · REPORT

STD Tests

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global STD Tests Market Analysis and Forecast 2026-2032

31 December 2025199 pages

Choose your research edition.

Industry ResearchSTD Tests Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal STD Tests Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal STD Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal STD Tests Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal STD Tests Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global STD Tests market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for STD Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for STD Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for STD Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for STD Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of STD Tests include Orasure, Hologic Inc., F. Hoffmann-La Roche, DiaSorin, Danaher Corporation, Cepheid Inc., Bio-Rad Laboratories, BioMerieux and Becton Dickinson and Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for STD Tests, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of STD Tests, also provides the revenue of main regions and countries. Of the upcoming market potential for STD Tests, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the STD Tests revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global STD Tests market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for STD Tests revenue, projected growth trends, production technology, application and end-user industry.

STD Tests Segment by Company

Orasure

Hologic Inc.

F. Hoffmann-La Roche

DiaSorin

Danaher Corporation

Cepheid Inc.

Bio-Rad Laboratories

BioMerieux

Becton Dickinson and Company

Alere Inc.

Affymetrix

Abbott Laboratories

STD Tests Segment by Type

HIV Testing

Hepatitis C Testing

Trichomonas’s Testing

Gonorrhoea Testing

Syphilis Testing

Chlamydia Testing

STD Tests Segment by Application

Diagnostic Centres

Hospitals

Homecare

Others

STD Tests Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global STD Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of STD Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of STD Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of STD Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of STD Tests company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, STD Tests revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global STD Tests Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. HIV Testing Major Player Table 3. Hepatitis C Testing Major Player Table 4. Trichomonas’s Testing Major Player Table 5. Gonorrhoea Testing Major Player Table 6. Syphilis Testing Major Player Table 7. Chlamydia Testing Major Player Table 8. Global STD Tests Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Diagnostic Centres Major Player Table 10. Hospitals Major Player Table 11. Homecare Major Player Table 12. Others Major Player Table 13. STD Tests Industry Trends Table 14. STD Tests Industry Drivers Table 15. STD Tests Industry Opportunities and Challenges Table 16. STD Tests Industry Restraints Table 17. Global STD Tests Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global STD Tests Market Size by Region (2021-2026) & (US$ Million) Table 19. Global STD Tests Market Share by Region (2021-2026) Table 20. Global STD Tests Market Size by Region (2027-2032) & (US$ Million) Table 21. Global STD Tests Market Share by Region (2027-2032) Table 22. Global STD Tests Revenue by Players (US$ Million) & (2021-2026) Table 23. Global STD Tests Revenue Market Share by Players (2021-2026) Table 24. Global STD Tests Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global STD Tests Key Players Headquarters & Area Served Table 26. Global STD Tests Players, Product Type & Application Table 27. Global STD Tests Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global STD Tests by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global STD Tests Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global STD Tests Revenue by Type (2021-2026) & (US$ Million) Table 32. Global STD Tests Revenue by Type (2027-2032) & (US$ Million) Table 33. Global STD Tests Revenue Market Share by Type (2021-2026) Table 34. Global STD Tests Revenue Market Share by Type (2027-2032) Table 35. Global STD Tests Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global STD Tests Revenue by Application (2021-2026) & (US$ Million) Table 37. Global STD Tests Revenue by Application (2027-2032) & (US$ Million) Table 38. Global STD Tests Revenue Market Share by Application (2021-2026) Table 39. Global STD Tests Revenue Market Share by Application (2027-2032) Table 40. Orasure Company Information Table 41. Orasure Business Overview Table 42. Orasure STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Orasure STD Tests Product Portfolio Table 44. Orasure Recent Development Table 45. Hologic Inc. Company Information Table 46. Hologic Inc. Business Overview Table 47. Hologic Inc. STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Hologic Inc. STD Tests Product Portfolio Table 49. Hologic Inc. Recent Development Table 50. F. Hoffmann-La Roche Company Information Table 51. F. Hoffmann-La Roche Business Overview Table 52. F. Hoffmann-La Roche STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. F. Hoffmann-La Roche STD Tests Product Portfolio Table 54. F. Hoffmann-La Roche Recent Development Table 55. DiaSorin Company Information Table 56. DiaSorin Business Overview Table 57. DiaSorin STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. DiaSorin STD Tests Product Portfolio Table 59. DiaSorin Recent Development Table 60. Danaher Corporation Company Information Table 61. Danaher Corporation Business Overview Table 62. Danaher Corporation STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Danaher Corporation STD Tests Product Portfolio Table 64. Danaher Corporation Recent Development Table 65. Cepheid Inc. Company Information Table 66. Cepheid Inc. Business Overview Table 67. Cepheid Inc. STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Cepheid Inc. STD Tests Product Portfolio Table 69. Cepheid Inc. Recent Development Table 70. Bio-Rad Laboratories Company Information Table 71. Bio-Rad Laboratories Business Overview Table 72. Bio-Rad Laboratories STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bio-Rad Laboratories STD Tests Product Portfolio Table 74. Bio-Rad Laboratories Recent Development Table 75. BioMerieux Company Information Table 76. BioMerieux Business Overview Table 77. BioMerieux STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BioMerieux STD Tests Product Portfolio Table 79. BioMerieux Recent Development Table 80. Becton Dickinson and Company Company Information Table 81. Becton Dickinson and Company Business Overview Table 82. Becton Dickinson and Company STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Becton Dickinson and Company STD Tests Product Portfolio Table 84. Becton Dickinson and Company Recent Development Table 85. Alere Inc. Company Information Table 86. Alere Inc. Business Overview Table 87. Alere Inc. STD Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Alere Inc. STD Tests Product Portfolio Table 89. Alere Inc. Recent Development Table 90. Affymetrix Company Information Table 91. Affymetrix Business Overview Table 92. Affymetrix STD Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Affymetrix STD Tests Product Portfolio Table 94. Affymetrix Recent Development Table 95. Abbott Laboratories Company Information Table 96. Abbott Laboratories Business Overview Table 97. Abbott Laboratories STD Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Abbott Laboratories STD Tests Product Portfolio Table 99. Abbott Laboratories Recent Development Table 100. North America STD Tests Revenue by Type (2021-2026) & (US$ Million) Table 101. North America STD Tests Revenue by Type (2027-2032) & (US$ Million) Table 102. North America STD Tests Revenue by Application (2021-2026) & (US$ Million) Table 103. North America STD Tests Revenue by Application (2027-2032) & (US$ Million) Table 104. North America STD Tests Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America STD Tests Revenue by Country (2021-2026) & (US$ Million) Table 106. North America STD Tests Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe STD Tests Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe STD Tests Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe STD Tests Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe STD Tests Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe STD Tests Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe STD Tests Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe STD Tests Revenue by Country (US$ Million) & (2027-2032) Table 114. China STD Tests Revenue by Type (2021-2026) & (US$ Million) Table 115. China STD Tests Revenue by Type (2027-2032) & (US$ Million) Table 116. China STD Tests Revenue by Application (2021-2026) & (US$ Million) Table 117. China STD Tests Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia STD Tests Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia STD Tests Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia STD Tests Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia STD Tests Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia STD Tests Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia STD Tests Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia STD Tests Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA STD Tests Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA STD Tests Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA STD Tests Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA STD Tests Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA STD Tests Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA STD Tests Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA STD Tests Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. STD Tests Image Figure 2. Global STD Tests Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global STD Tests Market Size Share 2021 VS 2025 VS 2032 Figure 4. HIV Testing Image Figure 5. Hepatitis C Testing Image Figure 6. Trichomonas’s Testing Image Figure 7. Gonorrhoea Testing Image Figure 8. Syphilis Testing Image Figure 9. Chlamydia Testing Image Figure 10. Global STD Tests Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global STD Tests Market Size Share 2021 VS 2025 VS 2032 Figure 12. Diagnostic Centres Image Figure 13. Hospitals Image Figure 14. Homecare Image Figure 15. Others Image Figure 16. Global STD Tests Market Size (US$ Million) & (2021-2032) Figure 17. Global STD Tests Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global STD Tests Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global STD Tests Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global STD Tests Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global STD Tests Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global STD Tests Revenue Market Share by Type (2021-2032) Figure 24. Global STD Tests Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global STD Tests Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global STD Tests Revenue Market Share by Application (2021-2032) Figure 27. North America STD Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America STD Tests Revenue Share by Type (2021-2032) Figure 29. North America STD Tests Revenue Share by Application (2021-2032) Figure 30. North America STD Tests Revenue Share by Country (2021-2032) Figure 31. United States STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe STD Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe STD Tests Revenue Share by Type (2021-2032) Figure 36. Europe STD Tests Revenue Share by Application (2021-2032) Figure 37. Europe STD Tests Revenue Share by Country (2021-2032) Figure 38. Germany STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China STD Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China STD Tests Revenue Share by Type (2021-2032) Figure 48. China STD Tests Revenue Share by Application (2021-2032) Figure 49. Asia STD Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia STD Tests Revenue Share by Type (2021-2032) Figure 51. Asia STD Tests Revenue Share by Application (2021-2032) Figure 52. Asia STD Tests Revenue Share by Region (2021-2032) Figure 53. Japan STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA STD Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA STD Tests Revenue Share by Type (2021-2032) Figure 61. SAMEA STD Tests Revenue Share by Application (2021-2032) Figure 62. SAMEA STD Tests Revenue Share by Country (2021-2032) Figure 63. Brazil STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt STD Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • HIV Testing
  • Hepatitis C Testing
  • Trichomonas’s Testing
  • Gonorrhoea Testing
  • Syphilis Testing
  • Chlamydia Testing
Applications
  • Diagnostic Centres
  • Hospitals
  • Homecare
  • Others
Companies covered
  • Orasure
  • Hologic Inc.
  • F. Hoffmann-La Roche
  • DiaSorin
  • Danaher Corporation
  • Cepheid Inc.
  • Bio-Rad Laboratories
  • BioMerieux
  • Becton Dickinson and Company
  • Alere Inc.
  • Affymetrix
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 STD Tests Market by Type
  3. 1.2.1 Global STD Tests Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 HIV Testing
  5. 1.2.3 Hepatitis C Testing
  6. 1.2.4 Trichomonas’s Testing
  7. 1.2.5 Gonorrhoea Testing
  8. 1.2.6 Syphilis Testing
  9. 1.2.7 Chlamydia Testing
  10. 1.3 STD Tests Market by Application
  11. 1.3.1 Global STD Tests Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Diagnostic Centres
  13. 1.3.3 Hospitals
  14. 1.3.4 Homecare
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 STD Tests Market Dynamics
  1. 2.1 STD Tests Industry Trends
  2. 2.2 STD Tests Industry Drivers
  3. 2.3 STD Tests Industry Opportunities and Challenges
  4. 2.4 STD Tests Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global STD Tests Market Perspective (2021-2032)
  2. 3.2 Global STD Tests Growth Trends by Region
  3. 3.2.1 Global STD Tests Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global STD Tests Market Size by Region (2021-2026)
  5. 3.2.3 Global STD Tests Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global STD Tests Revenue by Players
  2. 4.1.1 Global STD Tests Revenue by Players (2021-2026)
  3. 4.1.2 Global STD Tests Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global STD Tests Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global STD Tests Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global STD Tests Key Players Headquarters & Area Served
  7. 4.4 Global STD Tests Players, Product Type & Application
  8. 4.5 Global STD Tests Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global STD Tests Market CR5 and HHI
  11. 4.6.3 2025 STD Tests Tier 1, Tier 2, and Tier 3
5 STD Tests Market Size by Type
  1. 5.1 Global STD Tests Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global STD Tests Revenue by Type (2021-2032)
  3. 5.3 Global STD Tests Revenue Market Share by Type (2021-2032)
6 STD Tests Market Size by Application
  1. 6.1 Global STD Tests Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global STD Tests Revenue by Application (2021-2032)
  3. 6.3 Global STD Tests Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Orasure
  2. 7.1.1 Orasure Company Information
  3. 7.1.2 Orasure Business Overview
  4. 7.1.3 Orasure STD Tests Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Orasure STD Tests Product Portfolio
  6. 7.1.5 Orasure Recent Developments
  7. 7.2 Hologic Inc.
  8. 7.2.1 Hologic Inc. Company Information
  9. 7.2.2 Hologic Inc. Business Overview
  10. 7.2.3 Hologic Inc. STD Tests Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hologic Inc. STD Tests Product Portfolio
  12. 7.2.5 Hologic Inc. Recent Developments
  13. 7.3 F. Hoffmann-La Roche
  14. 7.3.1 F. Hoffmann-La Roche Company Information
  15. 7.3.2 F. Hoffmann-La Roche Business Overview
  16. 7.3.3 F. Hoffmann-La Roche STD Tests Revenue and Gross Margin (2021-2026)
  17. 7.3.4 F. Hoffmann-La Roche STD Tests Product Portfolio
  18. 7.3.5 F. Hoffmann-La Roche Recent Developments
  19. 7.4 DiaSorin
  20. 7.4.1 DiaSorin Company Information
  21. 7.4.2 DiaSorin Business Overview
  22. 7.4.3 DiaSorin STD Tests Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DiaSorin STD Tests Product Portfolio
  24. 7.4.5 DiaSorin Recent Developments
  25. 7.5 Danaher Corporation
  26. 7.5.1 Danaher Corporation Company Information
  27. 7.5.2 Danaher Corporation Business Overview
  28. 7.5.3 Danaher Corporation STD Tests Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Danaher Corporation STD Tests Product Portfolio
  30. 7.5.5 Danaher Corporation Recent Developments
  31. 7.6 Cepheid Inc.
  32. 7.6.1 Cepheid Inc. Company Information
  33. 7.6.2 Cepheid Inc. Business Overview
  34. 7.6.3 Cepheid Inc. STD Tests Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cepheid Inc. STD Tests Product Portfolio
  36. 7.6.5 Cepheid Inc. Recent Developments
  37. 7.7 Bio-Rad Laboratories
  38. 7.7.1 Bio-Rad Laboratories Company Information
  39. 7.7.2 Bio-Rad Laboratories Business Overview
  40. 7.7.3 Bio-Rad Laboratories STD Tests Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Rad Laboratories STD Tests Product Portfolio
  42. 7.7.5 Bio-Rad Laboratories Recent Developments
  43. 7.8 BioMerieux
  44. 7.8.1 BioMerieux Company Information
  45. 7.8.2 BioMerieux Business Overview
  46. 7.8.3 BioMerieux STD Tests Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BioMerieux STD Tests Product Portfolio
  48. 7.8.5 BioMerieux Recent Developments
  49. 7.9 Becton Dickinson and Company
  50. 7.9.1 Becton Dickinson and Company Company Information
  51. 7.9.2 Becton Dickinson and Company Business Overview
  52. 7.9.3 Becton Dickinson and Company STD Tests Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Becton Dickinson and Company STD Tests Product Portfolio
  54. 7.9.5 Becton Dickinson and Company Recent Developments
  55. 7.10 Alere Inc.
  56. 7.10.1 Alere Inc. Company Information
  57. 7.10.2 Alere Inc. Business Overview
  58. 7.10.3 Alere Inc. STD Tests Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Alere Inc. STD Tests Product Portfolio
  60. 7.10.5 Alere Inc. Recent Developments
  61. 7.11 Affymetrix
  62. 7.11.1 Affymetrix Company Information
  63. 7.11.2 Affymetrix Business Overview
  64. 7.11.3 Affymetrix STD Tests Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Affymetrix STD Tests Product Portfolio
  66. 7.11.5 Affymetrix Recent Developments
  67. 7.12 Abbott Laboratories
  68. 7.12.1 Abbott Laboratories Company Information
  69. 7.12.2 Abbott Laboratories Business Overview
  70. 7.12.3 Abbott Laboratories STD Tests Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Abbott Laboratories STD Tests Product Portfolio
  72. 7.12.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America STD Tests Revenue (2021-2032)
  2. 8.2 North America STD Tests Revenue by Type (2021-2032)
  3. 8.2.1 North America STD Tests Revenue by Type (2021-2026)
  4. 8.2.2 North America STD Tests Revenue by Type (2027-2032)
  5. 8.3 North America STD Tests Revenue Share by Type (2021-2032)
  6. 8.4 North America STD Tests Revenue by Application (2021-2032)
  7. 8.4.1 North America STD Tests Revenue by Application (2021-2026)
  8. 8.4.2 North America STD Tests Revenue by Application (2027-2032)
  9. 8.5 North America STD Tests Revenue Share by Application (2021-2032)
  10. 8.6 North America STD Tests Revenue by Country
  11. 8.6.1 North America STD Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America STD Tests Revenue by Country (2021-2026)
  13. 8.6.3 North America STD Tests Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe STD Tests Revenue (2021-2032)
  2. 9.2 Europe STD Tests Revenue by Type (2021-2032)
  3. 9.2.1 Europe STD Tests Revenue by Type (2021-2026)
  4. 9.2.2 Europe STD Tests Revenue by Type (2027-2032)
  5. 9.3 Europe STD Tests Revenue Share by Type (2021-2032)
  6. 9.4 Europe STD Tests Revenue by Application (2021-2032)
  7. 9.4.1 Europe STD Tests Revenue by Application (2021-2026)
  8. 9.4.2 Europe STD Tests Revenue by Application (2027-2032)
  9. 9.5 Europe STD Tests Revenue Share by Application (2021-2032)
  10. 9.6 Europe STD Tests Revenue by Country
  11. 9.6.1 Europe STD Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe STD Tests Revenue by Country (2021-2026)
  13. 9.6.3 Europe STD Tests Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China STD Tests Revenue (2021-2032)
  2. 10.2 China STD Tests Revenue by Type (2021-2032)
  3. 10.2.1 China STD Tests Revenue by Type (2021-2026)
  4. 10.2.2 China STD Tests Revenue by Type (2027-2032)
  5. 10.3 China STD Tests Revenue Share by Type (2021-2032)
  6. 10.4 China STD Tests Revenue by Application (2021-2032)
  7. 10.4.1 China STD Tests Revenue by Application (2021-2026)
  8. 10.4.2 China STD Tests Revenue by Application (2027-2032)
  9. 10.5 China STD Tests Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia STD Tests Revenue (2021-2032)
  2. 11.2 Asia STD Tests Revenue by Type (2021-2032)
  3. 11.2.1 Asia STD Tests Revenue by Type (2021-2026)
  4. 11.2.2 Asia STD Tests Revenue by Type (2027-2032)
  5. 11.3 Asia STD Tests Revenue Share by Type (2021-2032)
  6. 11.4 Asia STD Tests Revenue by Application (2021-2032)
  7. 11.4.1 Asia STD Tests Revenue by Application (2021-2026)
  8. 11.4.2 Asia STD Tests Revenue by Application (2027-2032)
  9. 11.5 Asia STD Tests Revenue Share by Application (2021-2032)
  10. 11.6 Asia STD Tests Revenue by Country
  11. 11.6.1 Asia STD Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia STD Tests Revenue by Country (2021-2026)
  13. 11.6.3 Asia STD Tests Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA STD Tests Revenue (2021-2032)
  2. 12.2 SAMEA STD Tests Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA STD Tests Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA STD Tests Revenue by Type (2027-2032)
  5. 12.3 SAMEA STD Tests Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA STD Tests Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA STD Tests Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA STD Tests Revenue by Application (2027-2032)
  9. 12.5 SAMEA STD Tests Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA STD Tests Revenue by Country
  11. 12.6.1 SAMEA STD Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA STD Tests Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA STD Tests Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst